Inflammatory pathways confer resistance to chemoradiotherapy in anal squamous cell carcinoma
RNA-seq (gene expression) · human · 98 samples
- What it is
- RNA-seq (gene expression)Gene activity measured by sequencing. The summary does not mention single-cell work, so this is most likely bulk: one average per sample, the usual starting point for comparing groups.
- Organism
- Homo sapiens (human)
- Topic
- Anal cancerThis series is part of our curated briefing on it.
- Samples
- 98 samples: 78 × cCR.ASCC vs 20 × PD.ASCCGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
- Paper
- Inflammatory pathways confer resistance to chemoradiotherapy in anal squamous cell carcinomaNPJ precision oncology · 2024
Read the full summary ↓
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE254331_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: For RNA-seq the counts are usually a table among the supplementary files (look for 'counts', 'expression', 'FPKM' or 'TPM' in the file name). The series matrix of a sequencing study is sometimes nearly empty.
Also filed as BioProject PRJNA1069754 and SRA study SRP486182. Searching any of these in the dataset finder brings you back here.
Supports a between-group comparison across 98 samples.
How we read this: 2 replicated groups read from 98 sample titles; they account for 98 of them. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM8037791 cCR.ASCC_1 cCR.ASCC
- GSM8037792 cCR.ASCC_10 cCR.ASCC
- GSM8037793 cCR.ASCC_100 cCR.ASCC
- GSM8037794 cCR.ASCC_101 cCR.ASCC
- GSM8037795 cCR.ASCC_102 cCR.ASCC
- GSM8037796 cCR.ASCC_103 cCR.ASCC
- GSM8037797 cCR.ASCC_105 cCR.ASCC
- GSM8037798 cCR.ASCC_11 cCR.ASCC
- GSM8037799 cCR.ASCC_12 cCR.ASCC
- GSM8037800 cCR.ASCC_13 cCR.ASCC
- GSM8037801 cCR.ASCC_14 cCR.ASCC
- GSM8037802 cCR.ASCC_15 cCR.ASCC
- GSM8037803 cCR.ASCC_16 cCR.ASCC
- GSM8037804 cCR.ASCC_17 cCR.ASCC
- GSM8037805 cCR.ASCC_18 cCR.ASCC
- GSM8037806 cCR.ASCC_19 cCR.ASCC
- GSM8037807 PD.ASCC_38 PD.ASCC
- GSM8037808 cCR.ASCC_2 cCR.ASCC
- GSM8037809 cCR.ASCC_20 cCR.ASCC
- GSM8037810 cCR.ASCC_21 cCR.ASCC
- GSM8037811 cCR.ASCC_22 cCR.ASCC
- GSM8037812 cCR.ASCC_24 cCR.ASCC
- GSM8037813 cCR.ASCC_25 cCR.ASCC
- GSM8037814 cCR.ASCC_26 cCR.ASCC
- GSM8037815 cCR.ASCC_27 cCR.ASCC
- GSM8037816 cCR.ASCC_28 cCR.ASCC
- GSM8037817 cCR.ASCC_3 cCR.ASCC
- GSM8037818 cCR.ASCC_30 cCR.ASCC
- GSM8037819 cCR.ASCC_32 cCR.ASCC
- GSM8037820 cCR.ASCC_34 cCR.ASCC
- GSM8037821 cCR.ASCC_35 cCR.ASCC
- GSM8037822 cCR.ASCC_36 cCR.ASCC
- GSM8037823 cCR.ASCC_38 cCR.ASCC
- GSM8037824 cCR.ASCC_4 cCR.ASCC
- GSM8037825 cCR.ASCC_40 cCR.ASCC
- GSM8037826 cCR.ASCC_44 cCR.ASCC
- GSM8037827 cCR.ASCC_45 cCR.ASCC
- GSM8037828 cCR.ASCC_47 cCR.ASCC
- GSM8037829 cCR.ASCC_49 cCR.ASCC
- GSM8037830 cCR.ASCC_5 cCR.ASCC
+ 58 more — browse all 98 samples with per-sample file links →
- GSE253560 Transcriptome and microbiome-immune changes across preinvasive and invasive anal cancer lesions 70 samples same disease briefing · shares anal
- GSE293618 Higher expression of HPV16 derived E7_LI Transcript Observed in Men with HIV and Recurrent Anal Cancer 12 samples same disease briefing · shares anal
- GSE301741 Single cell analysis highlights the significance of malignant cell IFN/MHC-II for immunotherapy response in head and neck squamous cell carcinoma 58 samples shares squamous, anal
- GSE203067 Single-Cell Transcriptomic Analysis of Primary and Metastatic Tumor Ecosystems in Esophageal Squamous Cell Carcinoma 21 samples shares squamous, anal
- GSE286827 4-1BB+ Tregs and inhibitory progenitor exhausted T cells confer resistance to anti-PD-L1 and anti-CTLA-4 combination therapy 87 samples shares resistance, confer
- GSE312235 Tumors Hijack Immune-Privileging Regulons via Distinct Cell Types to Confer T Cell Desertion and Immunotherapy Resistance Across Various Cancers 72 samples shares resistance, confer
- GSE309004 Molecular determinants of neoadjuvant chemotherapy resistance in breast cancer: An analysis of gene expression and tumor microenvironment 54 samples shares resistance, anal
- GSE268014 Spatial transcriptomic analysis of tumor heterogeneity in HPV+ and HPV- Head and Neck Squamous Cell Carcinoma 39 samples shares squamous, anal
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.